Bruce M. Ewenstein

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

Douglas W. Losordo, Timothy D. Henry, Charles J. Davidson et al. · Circulation Research · 2011 · 484 citations · Full text

Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors

Louis M. Aledort, Diana S. Beardsley, Herbert Cooper et al. · Thrombosis and Haemostasis · 1998 · 355 citations

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 320 citations

Factor Viii Levels, Medicine, Hematology +7

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

Marie Scully, Paul Knöbl, Karim Kentouche et al. · Blood · 2017 · 256 citations · Full text

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

Barbara A. Konkle, Oleksandra Stasyshyn, Pratima Chowdary et al. · Blood · 2015 · 250 citations · Full text